記事
BE Ventures Leads AcroCyte Therapeutics’ US$10 Million Financing Round to Accelerate Clinical Translation of the R³CE® Platform and U.S. Expansion
Professor Ying-Chih Chang
2026年8月26日
Professor Ying-Chih Chang
Hosted by BE Health News
